CompletedPhase 3

Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response

Iraq500 participantsStarted 2022-12-05

Plain-language summary

The goal of this clinical trial study is to investigate the role of anthropometric indices and Vit-D supplementation on BioNTech, Pfizer vaccine side effect and immunoglobulin G response against SARS-CoV-2 in individuals infected with COVID-19. The main question\[s\] it aims to answer are: 1. BMI has role in reduce BioNTech, Pfizer vaccine side effect 2. BMI has role in improve IgG titer 3. Vit-D supplementation has role in reduce BioNTech, Pfizer vaccine side effect 4. Vit-D supplementation has role in improve IgG titer

Who can participate

Age range30 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Who did not take the vaccine
✕. who take one dose of the vaccine
✕. who did not come back for another dose
✕. subjects who in the last 6 months received vitamin or mineral supplementation
✕. those with chronic conditions such as diabetes, hypertension, and heart disease, unwillingness to continue the study protocol, lactating women and pregnant women.

What they're measuring

Vit-D supplementation has role in reduce BioNTech, Pfizer vaccine side effect

Timeframe: 16 weeks

Trial details

NCT IDNCT05851313

SponsorSulaimani Polytechnic University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-10

View on ClinicalTrials.gov More COVID-19 Respiratory Infection trials